FTXHvsVHTETF Comparison
First Trust Nasdaq Pharmaceuticals ETF (FTXH) and Vanguard Health Care ETF (VHT) belong to the same industry segment: US Health Care. FTXH's top 1 sector exposures are Healthcare. In contrast, VHT's top sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. FTXH is more expensive with a Total Expense Ratio (TER) of 0.6%, versus 0.09% for VHT. FTXH is up 31.84% year-to-date (YTD) with +$1.02B in YTD flows. VHT performs worse with 17.43% YTD performance, and +$73M in YTD flows. Run a side-by-side ETF comparison of FTXH and VHT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
FTXH vs VHT performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FTXH VHT | +3.28%+4.29% | +9.09%+7.19% | +31.84%+17.43% | +47.80%+25.00% | +87.39%+56.18% | +77.36%+40.38% |
| Flows | FTXH VHT | +$41M-$17M | +$176M+$157M | +$1.02B+$73M | +$1.02B+$227M | +$1.02B-$2.04B | +$1.02B-$977M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FTXH VHT | +18.78%+16.33% | +17.62%+15.84% | +17.11%+14.83% | +16.43%+15.62% |
| Max drawdown | FTXH VHT | -5.45%-5.63% | -7.50%-10.39% | -19.32%-16.88% | -19.32%-17.77% |
| Max drawdown duration | FTXH VHT | 57d56d | 99d169d | 393d435d | 393d767d |
FTXH | VHT | |
Last sale 10/29/2026 at 1:30 PM | $43.77 | $341.93 |
| Previous close 10/28/2026 | $43.25 | $334.46 |
| Consolidated volume 10/28/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
FTXH | VHT | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
FTXH | VHT | |
|---|---|---|
| Last price | $43.77 | $341.93 |
| 1D performance | +1.22% | +2.23% |
| AuM | $1.16 B | $20.19 B |
| E/R | 0.6% | 0.09% |
FTXH | VHT | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | First Trust | Vanguard |
| Benchmark | NASDAQ US Smart Pharmaceuticals Index | MSCI US IMI Health Care 25/50 Index |
| N° of holdings | 49 | 412 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 20, 2016 | January 26, 2004 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
